Shelf-life 24 months at 5-37 °C • Portable and compact • Blood grouping on location • Result after just 2 minutes • Easy to learn, easy to use • No need for refrigeration and daily controls • Whole blood can be used down to 5 μl • No need for separation of red cells and blood plasma

Three-time Olympic Champion Runs with Eldon Biologicals to end postpartum Hemorrhage


In Kenya, Postpartum Hemorrhage (PPH) remains a significant challenge accounting for 25-45% of maternal deaths. To address this challenge the End PPH Project, of which Eldon Biologicals is a partner, held it inaugural End PPH Run to raise awareness of PPH and commence accelerated efforts to address the leading cause of maternal mortality. The inaugural End PPh Run took place in Nairobi on October 6.

At the event, the Health Cabinet Secretary, Dr Deborah Barasa called for urgent action to address the high rate of maternal deaths caused by PPH. Dr Barasa highlighted the need for a collaborative approach to tackle the issue. She stressed that even though Kenya has made progress a maternal mortality rate at 355 per 100,000 live births is still too high.

The Run was arranged by the Kenya Obstetrical and Gynecological Society (KOGS) and the Midwives Association of Kenya with support from Eldon Biologicals and other stakeholders.

Eldon Biologicals had in cooperation with Kenya Red Cross Society arranged that runners and spectators could donate blood, to help women experiencing PPH, and with the help of the EldonCard learn about their blood type.

One of the participants in the End PPH Run was Faith Kipyegon, a three-time Olympian Champion. A representative from Eldon Biologicals also joined the Run, and he is still in pain.

   

For additional reporting on the End PPH Run:

Cabinet Secretary Urges Action Against Postpartum Hemorrhage at Inaugural End Postpartum Hemorrhage (PPH) Run

Faith Kipyegon Runs to Raise Awareness for Postpartum Hemorrhage

For an interview with FIGO Presesident professor Anne Kihara, see:

Sidebar